Osteoarthritis (OA) is a very common problem seen in the primary care setting, but pharmacologic treatments do not alter the course of the disease and they are often associated with side effects or contraindicated in many older patients. Curcumin is an herbal treatment that has been shown to be effective for treating symptoms of OA. Join us for this episode as we discuss the evidence for curcumin in treating OA, and how to counsel patients on its use.

Join us as we review the United States Preventive Services Task Force’s (USPSTF) recently published draft recommendation statement on colorectal cancer (CRC) screening and the implications it has for primary care practice and your patients.

A recent study highlighted the lack of implementation of the 2017 guidelines for the prevention of peanut allergy in pediatric practices, highlighting the need for more awareness of these strategies in caring for children.

Patients with a history of transient ischemic attack (TIA) are at increased risk of stroke in the future. The ABCD2 score is the most used risk assessment tool for people with acute TIA, but it is not recommended for this purpose by the National Institute for Heath and Care Excellence (NICE). Join us for today’s episode as we describe a new validated risk assessment tool developed in Canada you can use to classify patients as low, medium, or high-risk for stroke over the 7 days following a TIA.

Data are limited regarding statin therapy for primary prevention of atherosclerotic cardiovascular disease in adults 75 years and older. During this episode we will review recent studies on the use of statins in elderly patients and discuss how to consider this data in your clinical practice.

Join us for this episode as we review the recently published (Dec. 2020) cohort study in JAMA on using bisphosphonates to prevent hip fractures. We will review the utility of bisphosphonates after 5 years and how to discuss their risks and benefits with patients.

This session will overview the new 2021 changes for outpatient E&M billing documentation requirements.

More than 250 million individuals worldwide have osteoarthritis (OA) of the knee and the burden on individuals and healthcare systems is enormous. There is no cure for OA, with treatments such as NSAIDs and acetaminophen aimed towards symptom reduction and improved functioning. Most evidence-based guidelines include the use of supportive shoes, however little evidence exists on effectiveness of these types of shoes. It is also unclear what the characteristics of a supportive shoe are and what type of shoe is best for OA. Join us as we discuss a recent randomized controlled trial that compared 2 types of shoes, and their benefits in symptom reduction and functional improvement of knee OA

The evidence of the impact of obesity and sedentary lifestyles on health and disease states is well established. Finding and applying strategies to assist people with the necessary behavior changes is a monumental task, but for Americans who are at lower income levels and in traditionally underserved populations, the evidence on what is effective is tragically lacking. The social determinants of health (SDOH) impact all aspects of care delivery, from access to care, to knowing what really works. Join us as we discuss a recent randomized controlled trial that evaluated a strategy that demonstrated weight loss in underserved populations, and may have promise to aid in this important aspect of care.

Clinical psychologist Dr. Christine Runyan joins me in today’s episode to discuss the various self-care methods to help healthcare workers overcome stressors related to the COVID-19 pandemic, and to describe the potential future impact of the COVID-19 crisis on this population.

Join us for this episode as we discuss a recent Cochrane review of the safety and effectiveness of topical treatments for toenail onychomycosis, and review when and how to prescribe these agents for patients.